HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
A comprehensive and multidimensional program, the event brought together several speakers:
Multiple objectives to support our growth in Asia:
The webinar was a resounding success, attracting an engaged audience and generating lots of positive feedback. Well done to all the teams involved—Marketing, Sales, and Innovation—for this exemplary international collaboration, which contributes to HTL’s reputation!
This October, HTL Biotechnology turned pink to support breast cancer prevention.
HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the ‘Energy – Climate’ category for its project to reduce carbon emissions from distillation systems.
The European Society of Cataract and Refractive Surgeons (ESCRS) is a unique opportunity each year to connect with our clients and partners while gaining insights into the key trends shaping the future of ophthalmology.